Desmopressin for Bedwetting in Children With SCD
Desmopressin as a Therapy for Nocturnal Enuresis in Pediatric Patients With Sickle Cell Disease
Sponsor: Montefiore Medical Center
Terminated
Study was not able to meet recruitment after 9 years of trying to enroll patients on different versions of the protocol and changing recruitment strategies.
Other terminated trials from Montefiore Medical Center
Other Anemia, Sickle Cell trials with similar outcome
A PHASE4 clinical study on Anemia, Sickle Cell and Nocturnal Enuresis, this trial is terminated or withdrawn. The trial is conducted by Montefiore Medical Center and has accumulated 11 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jun 2024 — Jul 2024 [monthly]
Terminated PHASE4
-
Mar 2024 — Jun 2024 [monthly]
Terminated PHASE4
▶ Show 6 earlier versions
-
Jul 2023 — Mar 2024 [monthly]
Terminated PHASE4
Status: Recruiting → Terminated
-
Jun 2022 — Jul 2023 [monthly]
Recruiting PHASE4
-
Sep 2021 — Jun 2022 [monthly]
Recruiting PHASE4
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE4
-
Oct 2020 — Jan 2021 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Jul 2020 — Oct 2020 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Montefiore Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .